| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |